888.900.4321
PharmaJetPharmaJet
PharmaJet
Needle-Free Injection Technology
  • HOME
  • ABOUT
  • PRODUCT
    • Needle-Free Technology
    • Stratis IM/SC
    • Tropis ID
    • Flu Application
  • RESOURCES
    • FAQs
    • Testimonials
    • Post Market Surveys
    • Publications
  • NEWS
    • News Releases
    • Articles
    • Press Coverage
  • GETTING STARTED
    • How to Use — Stratis IM/SC
    • How to Use – Tropis ID
    • Ordering Information
    • Marketing Materials
    • Needle-Free Flu Shot Clinics
  • PARTNER WITH US
  • CONTACT
Menu back  
 

Daily Archives: April 12, 2018

You are here:
  1. Home
  2. 2018
  3. April
  4. 12

Vaccibody moving forward with Cancer Neoantigen Vaccine Trial

GOLDEN, Colo. — April 17, 2018 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis® needle-free injection system.
April 12, 2018NewsBy Pharmajet Administrator
COPYRIGHT © 2021 PharmaJet, all rights reserved.